Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Neurodegenerative Disease Management|January 11, 2017
Subcutaneous peginterferon β-1a injection-site reaction experience and mitigation: Delphi analysis of the ALLOW studyBarry Hendin, DeRen Huang, Sibyl Wray, et al.Arthritis and Rheumatism|August 31, 2004
An analysis of CTLA-4 and proinflammatory cytokine genes in Wegener's granulomatosisYihua Zhou, DeRen Huang, Pamela L Paris, et al.Journal of Neuroimmunology|September 13, 2002
Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequenceXiong-Biao Wang, Maria Kakoulidou, Ricardo Giscombe, et al.Genes and Immunity|February 22, 2002
CDS1 and promoter single nucleotide polymorphisms of the CTLA-4 gene in human myasthenia gravisX B Wang, M Kakoulidou, Q Qiu, et al.Annals of Neurology|March 1, 2007
Inflammatory progressive multifocal leukoencephalopathy in human immunodeficiency virus-negative patientsDeRen Huang, Michael Cossoy, Meizhang Li, et al.International Journal of MS Care|August 24, 2016
Management Strategies for Flu-Like Symptoms and Injection-Site Reactions Associated with Peginterferon Beta-1a: Obtaining Recommendations Using the Delphi TechniqueJune Halper, Diego Centonze, Scott D Newsome, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 8, 2019
Patients transitioning from non-pegylated to pegylated interferon beta-1a have a low risk of new flu-like symptoms: ALLOW phase 3b trial resultsRobert T Naismith, Barry Hendin, Sibyl Wray, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2006
Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitisLiping Liu, Deren Huang, Masaru Matsui, et al.Patient Preference and Adherence|July 28, 2018
Treatment satisfaction significantly improves in patients with multiple sclerosis switching from interferon beta therapy to peginterferon beta-1a every 2 weeksBarry Hendin, Robert T Naismith, Sibyl E Wray, et al.Journal of Leukocyte Biology|November 13, 2004
Transgenic expression of CCL2 in the central nervous system prevents experimental autoimmune encephalomyelitisAdam Elhofy, Jintang Wang, Mari Tani, et al.Pageof 4